McKINNEY, Texas (December 17, 2018)—Soleo Health, a provider of complex specialty pharmacy and infusion services administered in the home and alternate sites of care, announced the opening of a new specialty infusion pharmacy location in Birmingham, Alabama. This expands the company’s footprint to 19 locations nationwide, with pharmacy licensure in all 50 states.
The 4,000 square-foot Soleo Health Birmingham pharmacy features a sterile pharmacy complex equipped with state-of-the-art compounding capabilities, designed to safely care for patients requiring specialty infusion to treat their complex or chronic conditions. The Birmingham pharmacy location, as with most of the company’s pharmacy locations, offers the flexibility for patients to receive their care in the comfort of the home or on-site in one of its three ambulatory infusion suites. Birmingham’s individual infusion suites provide patients the privacy they desire during their infusion treatments.
Soleo Health pharmacy locations serve patients requiring specialty infusion therapies, including immunoglobulin (IV and subcutaneous), specialty biologics, anti-infectives, parenteral nutrition, inotropic and factor replacement.
“The new Birmingham location joins our growing network of pharmacies we have built nationwide. We selected this area as a complement to our Mobile, Alabama, location and the market demand for high-quality specialty infusion services, in addition to our ability to attract talented and experienced staff members. From this location, we are reaching patients in Birmingham and extending services to the surrounding areas,” noted Drew Walk, chief executive officer.
“Patients prefer services provided by local, highly qualified nurses and pharmacists which leads to an enhanced patient experience and positive clinical outcomes. Health care providers trust Soleo with their patients because they are confident in the quality of care we deliver demonstrated through our proprietary clinical outcomes program, SoleMetrics,” Walk added.
Visit soleohealth.com for more information.
